Presently, Cord E. Dohrmann holds the position of Chief Scientific Officer at Evotec SE and Co-Managing Director at Evotec International GmbH (a subsidiary of Evotec SE).

He is also on the board of Eternygen GmbH and FSHD Unlimited Cooperatie Ua.

He previously was Chief Executive Officer of DeveloGen AG, Principal at The General Hospital Corp., Principal at Eberhard Karls Universität Tübingen and Principal at Duke University.

Dr. Dohrmann received a graduate degree from Max-Planck-Institute for Molecular Genetics, an undergraduate degree from Eberhard Karls Universität Tübingen and a doctorate from Harvard Medical School.